Our Company

Nobles Medical Technology II™ is reimagining the tools physicians have at their disposal for vascular and cardiovascular procedures—and is committed to revolutionizing cardiac surgery and cardiac interventions in the coming decade.  Improving patient outcomes, their overall clinical experience, and subsequent quality of life is central to our mission.
These goals can only be fulfilled by working in concert with the world’s most forward-looking doctors.  working with the top physicians in structural heart disease, beginning with the NobleStitch™ EL and expanding with our other suture based products including the HeartStitch® TA, HeartStitch MR and other cardiovascular suturing devices. Through Q3 of 2017, more than 600 patients have been treated in the UK, Germany, Sweden, Kazakhstan, Turkey, Switzerland, USA and Italy.

We consider innovation through making surgical procedures minimally invasive without introducing a significant change in the procedure to be the primary method of creating a medical device.  It is this creative principle which stands at the core of our company’s DNA, binding engineering, clinical expertise and design as one.  In order to expand the vision—and accelerate the timeline—of our product development process,  has recently launched an ambitious international expansion.  In addition to our Manufacturing and Research center in Southern California, we have expanded our Innovation Labs and international manufacturing and distribution centers in other parts of the world.
​
If you are a cardiac surgeon, interventional cardiologist, neurologist, academic, or medical-device engineer who shares our vision and commitment to rewriting the future of treatment of structural heart treatment, please contact us.

Contact Us

Board of Directors

Prof. Dr. Anthony Nobles

Chairmen of the Board

Prof. Dr. Nobles is Chairman and CEO of Nobles Medical Technologies 2, Inc., HeartStitch Medical, Inc., and Gyntle Care, Inc., and serves as a Director of the International Innovation Fund. With over 28 company foundations spanning electronics, medical devices, banking, automotive engineering, retail, and real estate, Prof. Nobles has made significant industry contributions. He is a Professor of Biomedical Engineering at Westsächsische Hochschule in Germany, a guest professor at Nazarbayev University’s School of Medicine and Business, and has invented over 155 medical devices, including the portable electronic book and advanced endoscopic imaging systems.

Prof. Nobles has successfully sold or licensed 27 companies to major corporations, including Medtronic, Johnson & Johnson, and Boston Scientific. He has authored numerous publications on topics such as endovascular surgery and neuroendoscopy, and has presented extensively at prestigious institutions like Harvard Medical School and international congresses. With 36 years of clinical experience across more than 12,000 cases, Prof. Dr. Nobles is a recognized educator, teaching Master Classes and clinical symposiums worldwide to top physicians in neurosurgery, cardiology, and cardiac surgery.

Benjamin Brosch

Director

Mr. Brosch served as the President of NMT2 from 2012 – 2016, and has served as a Director since 2012. Mr. Brosch has over 43 years of experience in engineering, manufacturing and management, with more than 26 years of experience in the Med-Device space. Mr. Brosch is a named inventor on several patents for innovative medical devices in the fields of general surgery, vascular surgery, neurosurgery, ObGyn, cardiac surgery and cardiology. Mr. Brosch has cofounded and served as an executive of several Med-Device companies. 

Clinical Advisory Board

Nobles Medical Technologies™ II collaborates with several internationally renowned physicians when designing and implementing its products and technologies.  Several of these top physicians from the key areas of clinical practice are members of the NMT2 Clinical Advisory Board.

​Dr. William Cohn

Cardiac Surgeon

• Director, Center for Technology and Innovation;
• Associate Director, Laboratory Surgery Research in the Center for Cardiac Support;
• Co-director, Cullen Cardiovascular Research Laboratory Texas Heart Institute at CHI St. Luke’s Health - Baylor St. Luke’s Medical Center.

Prof. Dr. Jan-Peter Warnke

Neurosurgeon

​Chief of Neurosurgery for Paracelsus Klinken in Zwickau Germany. Dr. Warnke serves as Professor at the West Sachsen Hochscule in Zwickau.

Dr. John Crew

Vascular Surgeon

In Memory of Dr. John Crew, Vascular Surgeon who passed away from stroke, the very disease he was helping to reduce with his efforts at NMT II.
.
​Dr. Crew, was a vascular surgeon and medical director of Seton’s Advanced Wound Care Center, board certified in vascular surgery, endovascular procedures, and peripheral angioplasty. He served as the Director of Cardiovascular Surgical Research for the San Francisco Heart Institute at Seton Medical Center. Dr. Crew also held several patents for suturing and device design.